The Globe and Mail reports in its Wednesday, Jan. 10, edition that ahead of the release of Centerra Gold's 2024 guidance, Desjardins Securities analyst John Sclodnick trimmed his share target to $11.75 from $12 with a "buy" recommendation. The Globe's David Leeder writes that Mr. Sclodnick says Centerra is his "preferred gold producer pick." Mr. Sclodnick says in a note: "We have reduced our 2024 copper production and increased our gold production estimates to better reflect the latest comments from management, including on the 3Q conference call, and believe that guidance should be relatively in line with our revised production estimates. However, our AISC [all-in sustaining cost] estimate appears to be the Street high and we see risk that 2024 guidance will come in above consensus. However, beyond the guidance announcement, we continue to like Centerra for its best-in-class return-of-capital program, and potential NAV accretion through mine-life extension at Mount Milligan and Oksut, where we model only reserves. Additionally, the company could surface value at its molybdenum business and Goldfields project, and any discoveries at its portfolio of 25 exploration interests are not currently priced into our NAV."